Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway

Irisin administration lowered salt-sensitive hypertension through regulating RAC1-MR signaling via activation of AMPK, which may be a promising therapeutic approach for salt-sensitive hypertension.